Clinical Trials Browser

Smoldering Multiple Myeloma × Denosumab × Clear all

NCT03839459 2026-01-28

Denosumab for Smoldering Multiple Myeloma

Phase 2 Completed

20 enrolled 8 charts

Smoldering Multiple Myeloma

NCT03792763 2025-02-11

DEFENCE

Phase 2 Completed

Smoldering Multiple Myeloma, Multiple Myeloma